N@N

KENDLE INTERNATIONAL INC (NASDAQ:KNDL), Down By 25.72% ($3.12) From $12.130 After BUYINS.NET Report Predicted Weakness After Ea

^{Published on 2011-03-04 08:03:06 - WOPRAI}
 

March 4, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Tuesday, March 1st 2011 stating that KENDLE INTERNATIONAL INC (NASDAQ:KNDL) was expected to be Down After its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=kndl&id=150375

At the time this story was written, KENDLE INTERNATIONAL INC (NASDAQ:KNDL) is Down By 25.72% ($3.12) From $12.130 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

KENDLE INTERNATIONAL INC (NASDAQ:KNDL) - Kendle International Inc., a clinical research organization, provides Phase I-IV clinical development services on a contract basis to the biopharmaceutical industry worldwide. The company operates through two segments: Early Stage and Late Stage. The Early Stage segment focuses on the high-end scientific exploratory medicine area, from first-in-human studies to proof-of-concept stages. This segment also supports Phase I studies in established compounds, including bioequivalence and pharmacokinetics studies. The Late Stage segment conducts Phase II to IV clinical trials, as well as provides a range of services, including clinical monitoring, investigator recruitment, patient recruitment, data management, and study reports to assist customers with their drug development process. This segment also oversees various steps of a study, from award to close out of a study; designs and conducts Phase IIIB and IV studies; focuses on health economics and outcomes research, observational studies, scientific events, and medical education services; and provides services to the federal government and health care foundation oriented organizations. In addition, it offers regulatory and consulting services at every stage of drug and device development, as well as designs clinical programs and clinical trial protocols, reviews programs, and provides gap analysis to assist sponsors in achieving their clinical development strategies; offers consulting services for nonclinical development for small molecules, biologicals, vaccines, and devices; assists with the U.S. Food and Drug Administration application process; and assists customers with the collection, analysis, and reporting of drug safety data. Further, this segment offers statistical support for Phase I to IV clinical trials and submissions. Kendle International Inc. operates in North America, Europe, Asia/Pacific, Latin America, and Africa. The company was founded in 1981 and is based in Cincinnati, Ohio.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. KENDLE INTERNATIONAL INC (NASDAQ:KNDL) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net